AU2001260414A1 - Pharmaceutical compositions for transdermal administration of anti-inflammatory agents - Google Patents

Pharmaceutical compositions for transdermal administration of anti-inflammatory agents

Info

Publication number
AU2001260414A1
AU2001260414A1 AU2001260414A AU6041401A AU2001260414A1 AU 2001260414 A1 AU2001260414 A1 AU 2001260414A1 AU 2001260414 A AU2001260414 A AU 2001260414A AU 6041401 A AU6041401 A AU 6041401A AU 2001260414 A1 AU2001260414 A1 AU 2001260414A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
inflammatory agents
transdermal administration
transdermal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260414A
Inventor
Brigitte Illel
Jean-Pierre Vergnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU2001260414A1 publication Critical patent/AU2001260414A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001260414A 2000-05-12 2001-05-11 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents Abandoned AU2001260414A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0006048A FR2808685B1 (en) 2000-05-12 2000-05-12 PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ANTI-INFLAMMATORY AGENTS
FR0006048 2000-05-12
PCT/FR2001/001442 WO2001085143A2 (en) 2000-05-12 2001-05-11 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents

Publications (1)

Publication Number Publication Date
AU2001260414A1 true AU2001260414A1 (en) 2001-11-20

Family

ID=8850140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260414A Abandoned AU2001260414A1 (en) 2000-05-12 2001-05-11 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents

Country Status (6)

Country Link
US (2) US20030152611A1 (en)
EP (1) EP1283704B1 (en)
JP (1) JP5149477B2 (en)
AU (1) AU2001260414A1 (en)
FR (1) FR2808685B1 (en)
WO (1) WO2001085143A2 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20030118655A1 (en) * 2001-12-21 2003-06-26 Nikhil Kundel Film forming liquid composition
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
JP4807721B2 (en) * 2004-01-29 2011-11-02 株式会社 メドレックス Anti-inflammatory analgesic topical
DE102004011686A1 (en) * 2004-03-10 2005-09-29 Novosis Ag Dermal or transdermal therapeutic system with matrix component of renewable tubing
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US7772213B2 (en) * 2006-07-27 2010-08-10 Nathan Strick Composition for the treatment of inflammatory conditions
WO2008050491A1 (en) * 2006-10-24 2008-05-02 Japan Health Science Research Center.Ltd. Film preparation for forming film on skin
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PL1986473T3 (en) * 2007-04-03 2017-07-31 Tsinghua University Organic electroluminescent device
CN105820107B (en) 2007-06-04 2022-09-09 泰飞尔公司 Prodrug of non-steroidal anti-inflammatory drug with rapid skin and biological membrane penetration speed and novel medical application thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
KR20200022525A (en) 2008-12-04 2020-03-03 충시 위 High Penetration Compositions and Their Applications
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
WO2011061155A1 (en) 2009-11-17 2011-05-26 Bayer Consumer Care Ag Antifungal formulations and their use
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
US9205041B2 (en) 2011-05-03 2015-12-08 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof
KR20140027319A (en) * 2011-05-26 2014-03-06 노파르티스 아게 Compositions for percutaneous administration of physiologically active agents
GB201120908D0 (en) * 2011-12-06 2012-01-18 Reckitt Benckiser Healthcare Patch containing non-steroidal anti-inflammatory drug
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
CA3082286A1 (en) 2017-12-04 2019-06-13 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976223A (en) * 1972-02-02 1976-08-24 Carter-Wallace, Inc. Aerosol package
US3788521A (en) * 1972-07-10 1974-01-29 Laauwe Robert H Aerosol package
JPS59216822A (en) * 1983-05-26 1984-12-06 Terumo Corp Film-forming preparation for external application
JP2570342B2 (en) * 1987-12-01 1997-01-08 日産化学工業株式会社 External solution
EP0450123B1 (en) * 1990-04-05 1995-07-05 Knoll AG Pharmaceutical composition for topical administration containing diclofenac-sodium
US5350769A (en) * 1990-10-30 1994-09-27 Ss Pharmaceutical Co., Ltd. Antiinflammatory gel preparation
JP3191219B2 (en) * 1990-12-28 2001-07-23 三笠製薬株式会社 Systemic transdermal formulation
US5985860A (en) * 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
JPH06321771A (en) * 1992-07-31 1994-11-22 Tanabe Seiyaku Co Ltd Base for percutaneous administration
FR2732223B1 (en) * 1995-03-30 1997-06-13 Sanofi Sa PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
AU2189499A (en) * 1998-02-09 1999-08-23 Chong Kun Dang Pharmaceutical Corp. Piroxicam-containing hydroalcoholic gel composition
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping

Also Published As

Publication number Publication date
FR2808685A1 (en) 2001-11-16
US20030152611A1 (en) 2003-08-14
JP2003532668A (en) 2003-11-05
FR2808685B1 (en) 2004-10-08
WO2001085143A3 (en) 2002-05-10
US20070071688A1 (en) 2007-03-29
JP5149477B2 (en) 2013-02-20
WO2001085143A2 (en) 2001-11-15
EP1283704B1 (en) 2013-12-18
EP1283704A2 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
AU2001260414A1 (en) Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
AU2513900A (en) Drug dosage unit for buccal administration of steroidal active agents
AU762322C (en) Novel galenic formulations of meloxicam for oral administration
HUP0301921A3 (en) Sustained release pharmaceutical compositions for paranteral administration of hydrophilic compounds
AU1928501A (en) Formulations for pharmaceutical agents ionizable as free acids or free bases
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
GB2355656B (en) Pharmaceutical compositions for oral and topical administration
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU5460800A (en) Pharmaceutical transdermal compositions
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
AU4170299A (en) Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
AU2002221365A1 (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
AU2001274420A1 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
AU2003251643A1 (en) Pharmaceutical compositions containing keto-acids for endoperitoneal administration
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
GB9902227D0 (en) Pharmaceutical composition for topical administration
AU2003235931A1 (en) Vintoperol-containing medicinal composition for transdermal administration
AU2001261746A1 (en) Topical administration of pharmacological compositions for non-systemic treatment of pruritus